Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 May:60:159-64.
doi: 10.1289/ehp.8560159.

Clinical evaluation of liver structure and function in humans exposed to halogenated hydrocarbons

Clinical evaluation of liver structure and function in humans exposed to halogenated hydrocarbons

P S Guzelian. Environ Health Perspect. 1985 May.

Abstract

An unresolved question is whether humans exposed to comparatively low doses of persistent environmental chemicals such as polyhalogenated biphenyls or organochlorine pesticides are at risk for injury to the liver. Cross-sectional epidemiologic studies suggest that these chemicals may produce statistically significant but clinically mild abnormalities in the commonly employed chemical tests of liver function. The few reports of human liver morphology reveal nonspecific changes reflecting effects of lipophilic chemicals. There is evidence that chemicals of this category in at least some doses cause induction of liver microsomal enzymes involved in biotransformation of foreign substances. This finding has been documented by measurements of the clearance of model drugs or the appearance in the urine of steroid metabolites or glucaric acid. Although a positive statistical correlation between the concentrations of these chemicals in serum and the serum gamma-glutamyltranspeptidase activity has been reported, the non-specificity of the latter enzyme precludes conclusion that this change is indicative of induction of liver microsomal enzymes. Although the effects of this type of environmental chemical are not indicative of progressive liver disease, only prospective clinical trials can resolve the issue of the risk for future development of liver malignancy.

PubMed Disclaimer

Similar articles

References

    1. Br Heart J. 1965 Sep;27(5):688-90 - PubMed
    1. Arch Immunol Ther Exp (Warsz). 1963;11:1-61 - PubMed
    1. Clin Chem. 1969 Feb;15(2):124-36 - PubMed
    1. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):638-42 - PubMed
    1. Clin Pharmacol Ther. 1970 Sep-Oct;11(5):724-32 - PubMed

Publication types

MeSH terms

LinkOut - more resources